Masayoshi Takashima, MD
Otolaryngology · Houston, TXNPI 1407895477
Payments from drug & device makers
Across 269 payments — averaging $2394.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$419K
- Aerin Medical Inc.$94K
- Neurent Medical Limited$46K
- Spirair, Inc.$39K
- Medtronic$33K
- Acclarent, Inc$5K
- plus $9K from 17 others
Across 4 payments — averaging $9558.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$38K
What the payments were for
- Consulting fees$116,21470%
- Speaking & faculty fees$25,37715%
- Travel & lodging$15,3309%
- Food & beverage$9,8666%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 42 | $418,633 |
| Aerin Medical Inc. | 55 | $93,985 |
| Neurent Medical Limited | 24 | $45,856 |
| Spirair, Inc. | 7 | $39,292 |
| Medtronic(2 entities) | 73 | $32,691 |
| Acclarent, Inc | 12 | $4,957 |
| Intersect ENT, Inc. | 10 | $3,154 |
| Sanofi | 8 | $2,493 |
| Histosonics, Inc. | 1 | $793 |
| Optinose US, Inc. | 3 | $557 |
| Inspire Medical Systems, Inc. | 16 | $478 |
| Integra Lifesciences Corporation | 3 | $260 |
| Stryker | 3 | $224 |
| KARL Storz Endoscopy-america | 2 | $124 |
| Intuitive Surgical | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| Amgen | 1 | $90 |
| AstraZeneca | 1 | $56 |
| Olympus America Inc. | 1 | $53 |
| Merck | 2 | $40 |
| Ambu Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$72,690
- NEUROMARK Radiofrequency Console$31,482
- NEUROMARK Device$31,182
- RHINAER STYLUS$13,345
- SeptAlign$10,316
- TURBALIGN$8,732
- THN Sleep Therapy$7,892
- ENDO-SCRUB$7,405
- PROPEL$7,241
- TruDi Nav Suction$4,000
- ACCLARENT Balloon Inflation Device$4,000
- STEALTHSTATION S8 PLATFORM$3,402
- VivAer$1,620
- RhinAer$1,620
- StealthStation$754
- Xhance$534
- NEUROMARK System$300
- DUPIXENT$300
- Vivaer RF Stylus$292
- SINUVA$270
How this compares
$643,990 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 94 | $2,838 |
| Fluticasone Propionate | 30 | $497 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $307 |
| Azelastine Hcl | 16 | $265 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $116 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Houston
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Stephen LaiHouston$968K
- Amber LuongHouston$793K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$336K
- William YaoHouston$280K
- Martin CitardiHouston$264K
- Michael KaplanHouston$202K
- Andrew HuangHouston$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.